Comments
Bayer says drug shows promise vs. gastrointestinal cancer
04.06.2012. | FRANKFURT (Reuters) - German drugmaker Bayer said trials showed its potential blockbuster regorafenib prolonged the lives of patients with an aggressive type of gastrointestinal cancer without their tumors worsening, and it will seek approval for wider use of the drug....
